Evercore ISI Group Upgrades CVS Health to Outperform, Raises Price Target to $83
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Elizabeth Anderson has upgraded CVS Health from In-Line to Outperform and raised the price target from $81 to $83.
September 19, 2023 | 10:20 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CVS Health has been upgraded to Outperform by Evercore ISI Group, with a raised price target of $83.
The upgrade from In-Line to Outperform by Evercore ISI Group indicates a positive outlook for CVS Health. The raised price target from $81 to $83 suggests that the analyst expects the stock to perform better in the future. This could lead to increased investor interest and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100